Brief: Interpace Biosciences Announces Full Year And Fourth Quarter 2019 Financial And Business Results And Preliminary Q1-2020 Results

Interpace Biosciences

22/04/2020 21:41

April 22 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE BIOSCIENCES ANNOUNCES FULL YEAR AND FOURTH
QUARTER
2019 FINANCIAL AND BUSINESS RESULTS AND PRELIMINARY Q1-2020
RESULTS
    * Q4 REVENUE FELL 30 PERCENT TO $4.1 MILLION
    * SEES Q1 2020 REVENUE $8.8 MILLION TO $9.3 MILLION
    * Q4 REVENUE ESTIMATE $10.8 MILLION -- REFINITIV IBES DATA
    * WITHDRAWS FULL-YEAR 2020 GUIDANCE
    * EXPECTS TO LAUNCH COVID-19 SEROLOGY TESTING IN Q2-2020
    * QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $2.88
    * Q1 EARNINGS PER SHARE VIEW $-0.55, REVENUE VIEW $11.4
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbCfSnL 
Further company coverage:  IDXG.O 

 ((Briefs@thomsonreuters.com;))